UNSPSC 51262907: Propranolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C16H21NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9Y8NXQ24VQ, chemically known as 2-propanol, 1- (isopropylamino)-3-(1-naphthyloxy)-, hydrochloride but generally known as propranolol, which bears US NIH Compound Identifier 4946. European Medicines Agency schedules Propranolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10119MIG. The term PROPRANOLOL is an International Non-Proprietary Name.

UNSPSC 51262907 Propranolol is a Commodity-tier code nominally identifying a specific beta-blocker pharmaceutical, but recent state and local solicitation activity tagged under this code shows minimal relevance to propranolol itself. The Seminole County, Florida procurement (IFB 60459723LAS, due July 26, 2023) sought naloxone and drug deactivation systems for community health initiatives—opioid-reversal and harm-reduction products entirely outside the scope of a cardiac or hypertension medication. The Texas Health and Human Services Commission RFI (HHS0017013, posted April 3, 2026) solicited vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, a market-intelligence and contracting-strategy exercise with no specific pharmaceutical named. The code shows little recent activity directly aligned with propranolol procurement by state and local agencies.

Geographic activity is limited to Florida and Texas based on the two records in the opportunity block, with no pattern of sustained or repeated procurement under this code designation. The mismatch between the nominal commodity (propranolol) and the actual work being solicited (naloxone distribution and pharmacy benefit program strategy) suggests either a cataloging error in how opportunities were tagged or that state and local buyers rarely use this specific code to flag propranolol purchases. Unless additional opportunities emerge showing direct propranolol procurement by state departments, counties, school districts, or other public bodies, this code presents negligible market signal for business development purposes in the state and local space.